Roberts Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $216K | Sell |
485
-89
| -16% | -$39.6K | 0.16% | 77 |
|
|
2025
Q1 | $278K | Hold |
574
| – | – | 0.24% | 83 |
|
|
2024
Q4 | $231K | Hold |
574
| – | – | 0.19% | 80 |
|
|
2024
Q3 | $267K | Hold |
574
| – | – | 0.23% | 82 |
|
|
2024
Q2 | $240K | Hold |
574
| – | – | 0.23% | 85 |
|
|
2024
Q1 | $240K | Buy |
+574
| New | +$240K | 0.23% | 85 |
|
|
2022
Q3 | $178K | Hold |
616
| – | – | 0.26% | 85 |
|
|
2022
Q2 | $174K | Hold |
616
| – | – | 0.24% | 84 |
|
|
2022
Q1 | $161K | Hold |
616
| – | – | 0.17% | 95 |
|
|
2021
Q4 | $135K | Buy |
+616
| New | +$135K | 0.13% | 94 |
|